Fig. 6 | Leukemia

Fig. 6

From: A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

Fig. 6

Comparison of Rd continuous vs MPT for PFS (a) using frailty subgroups with and without ISS stage, and comparison of Rd continuous vs MPT for OS (b) using frailty subgroups with and without ISS stage. MPT Melphalan + Prednisone + Thalidomide, PFS Progression-Free Survival, ISS International Staging System, OS Overall Survival

Back to article page